These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16903455)

  • 1. Maintaining the viability and safety of the methadone maintenance treatment program.
    Breslin KT; Malone S
    J Psychoactive Drugs; 2006 Jun; 38(2):157-60. PubMed ID: 16903455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Earning "take-home" privileges and long-term outcome in a methadone maintenance treatment program.
    Peles E; Schreiber S; Sason A; Adelson M
    J Addict Med; 2011 Jun; 5(2):92-8. PubMed ID: 21769054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone maintenance therapy in residential therapeutic community settings: challenges and promise.
    Greenberg B; Hall DH; Sorensen JL
    J Psychoactive Drugs; 2007 Sep; 39(3):203-10. PubMed ID: 18159773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing methadone medical maintenance in community-based clinics: disseminating evidence-based treatment.
    King VL; Burke C; Stoller KB; Neufeld KJ; Peirce J; Kolodner K; Kidorf M; Brooner RK
    J Subst Abuse Treat; 2008 Oct; 35(3):312-21. PubMed ID: 18294805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Philadelphia's community based drug abuse program: broader medical and social concepts.
    Schut J
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):286-91. PubMed ID: 1167235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone medical maintenance in primary care. An implementation evaluation.
    Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
    J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
    Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S
    J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel.
    Peles E; Schreiber S; Adelson M
    Drug Alcohol Depend; 2006 May; 82(3):211-7. PubMed ID: 16219428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple substance use among heroin-dependent patients before and during attendance at methadone maintenance treatment program, Yunnan, China.
    Li L; Sangthong R; Chongsuvivatwong V; McNeil E; Li J
    Drug Alcohol Depend; 2011 Jul; 116(1-3):246-9. PubMed ID: 21282020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
    Peles E; Schreiber S; Adelson M
    Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excusing exclusion: Accounting for rule-breaking and sanctions in a Swedish methadone clinic.
    Petersson FJ
    Int J Drug Policy; 2013 Nov; 24(6):e99-e104. PubMed ID: 24183330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
    Gelkopf M; Weizman T; Melamed Y; Adelson M; Bleich A
    Isr J Psychiatry Relat Sci; 2006; 43(2):126-36. PubMed ID: 16910375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients.
    Peles E; Kreek MJ; Kellogg S; Adelson M
    J Addict Dis; 2006; 25(1):43-50. PubMed ID: 16597572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach for treating methadone patients created.
    Hosp Peer Rev; 2008 Jul; 33(7):98-100. PubMed ID: 19035035
    [No Abstract]   [Full Text] [Related]  

  • 18. Methadone maintenance therapy and chronic pain.
    Streltzer J; Kosten TR
    JAMA; 2003 Nov; 290(18):2403; author reply 2403-4. PubMed ID: 14612466
    [No Abstract]   [Full Text] [Related]  

  • 19. Trends and predictors in methadone maintenance treatment dropout in Shanghai, China: 2005-2011.
    Ren J; Ning Z; Asche CV; Zhuang M; Kirkness CS; Ye X; Fu J; Pan Q
    Curr Med Res Opin; 2013 Jul; 29(7):731-8. PubMed ID: 23590648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does maintenance treatment reduce the mortality rate of opioid addicts?].
    Scherbaum N; Specka M; Hauptmann G; Gastpar M
    Fortschr Neurol Psychiatr; 2002 Sep; 70(9):455-61. PubMed ID: 12215918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.